Troubled Vaccine Maker and Its Founder Gave $2 Million in Political Donations
Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending.
Fuad El-Hibri, third from left, the founder and executive chairman of Emergent BioSolutions, shaking hands with Robert Ehrlich, then the governor of Maryland, at an Emergent site in Frederick, Md., in 2004.Credit.Grant L. Gursky
May 18, 2021, 7:53 p.m. ET
WASHINGTON When Fuad El-Hibri, founder and executive chairman of Emergent BioSolutions, appears Wednesday before a House subcommittee to explain how the company’s Baltimore plant ruined millions of doses of coronavirus vaccine, he will be questioned by lawmakers he and his employees spent tens of thousands of dollars helping to elect.
The government has so far paid Emergent BioSolutions $271 million, even though American regulators have yet to clear a single dose of vaccine produced at its manufacturing plant in Baltimore.
Biden Signs Executive Order to Bolster Federal Governmentâs Cybersecurity
President Bidenâs order places strict new standards on software sold to the government.
Colonial Pipeline said on Wednesday that it had restarted operations, but that it could take several days for energy to flow normally.Credit.Travis Dove for The New York Times
May 12, 2021, 9:36 p.m. ET
WASHINGTON â As the East Coast suffered from the effects of a ransomware attack on a major petroleum pipeline, President Biden signed an executive order on Wednesday that placed strict new standards on the cybersecurity of any software sold to the federal government.
Shake-Up at Covid Vaccine Manufacturer That Tossed Millions of Doses
Emergent BioSolutions’ C.E.O. announced several executive changes but vigorously defended the company, which is on track for record revenues.
Production was halted this month at the Emergent plant in Baltimore where up to 15 million doses of Johnson & Johnson vaccine had to be scrapped.Credit.Saul Loeb/Agence France-Presse Getty Images
April 29, 2021
WASHINGTON Executives of Emergent BioSolutions, the Covid-19 vaccine manufacturer that was forced to discard up to 15 million doses because of possible contamination, reported a shake-up in leadership on Thursday and offered the most fulsome defense yet of the company’s performance.